# Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

Study · id `cardio:ct-nct03710291` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03710291](<https://clinicaltrials.gov/study/NCT03710291>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03710291

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1480 participants.

## Technical summary

Registry record NCT03710291. Randomized; quadruple masking; primary purpose treatment. Start 2018-11-20 (actual); primary completion 2022-08-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1480 participants (enrolled count; ClinicalTrials.gov record NCT03710291, source copy `cardio:ctgov-nct03710291-2022-10-14`, retrieved 2026-10-26)
- Started: 2018-11-20 (actual) (ClinicalTrials.gov record NCT03710291, source copy `cardio:ctgov-nct03710291-2022-10-14`, retrieved 2026-10-26)
- Primary completion: 2022-08-23 (actual) (ClinicalTrials.gov record NCT03710291, source copy `cardio:ctgov-nct03710291-2022-10-14`, retrieved 2026-10-26)
- Completion: 2022-09-27 (actual) (ClinicalTrials.gov record NCT03710291, source copy `cardio:ctgov-nct03710291-2022-10-14`, retrieved 2026-10-26)
- Countries: United States; Albania; Argentina; Armenia; Australia; Belarus; Belgium; Brazil; Bulgaria; Canada; Chile; Colombia; Czechia; France; Georgia; Hong Kong SAR China; Hungary; Israel; Italy; Malaysia; Mexico; Netherlands; North Macedonia; Poland; Portugal; Romania; Serbia; Singapore; Slovakia; South Korea; Spain; Taiwan; Ukraine; United Kingdom (ClinicalTrials.gov record NCT03710291, source copy `cardio:ctgov-nct03710291-2022-10-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03710291-2022-10-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
- Acronym: VALOR-CKD
- Condition: Metabolic Acidosis
- Condition: Chronic Kidney Disease
- Intervention (Drug): TRC101
- Intervention (Drug): Placebo
- Lead sponsor: Tricida, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis (`cardio:pubmed-38261535`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 86a45b4afa25360ffab4e946abfa37cf9c785ecfb1be185ef25410f5db945137
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
